Filing Details

Accession Number:
0001213900-20-025331
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-04 09:00:44
Reporting Period:
2020-09-03
Accepted Time:
2020-09-04 09:00:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1522602 Cohbar Inc. CWBR Pharmaceutical Preparations (2834) 261299952
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1791221 Misha Petkevich C/O Cohbar, Inc.
1455 Adams Drive, Suite 2050
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-03 11,000 $1.02 240,609 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. Represents the weighted average purchase price. The lowest price at which shares were purchased was $1.01 and the highest price at which shares were purchased was $1.05. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares purchased at each separate price within the ranges set forth in this footnote 1 to this Form 4
  2. The Reporting Person is a General Partner of V2M Life Sciences L.P. ("V2M"), and has sole voting and dispositive power over the securities held by V2M. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.